The KDIGO webinar series on Implementing Genetic Testing for CKD in the Real World Setting provides a comprehensive program covering foundational principles, result interpretation, clinical utility, and future directions in renal genetics. Modules 2 – 4 will be CME-accredited.
Module 1
In Module 1 of KDIGO’s four-part webinar series, Foundational Principles in the Role of Genetics for CKD Management, Professors Andrew Mallett, MD (Australia), Hila Rasouly, MD (United States), and Ali Gharavi, MD (United States) discuss key messages from KDIGO Guidelines on the prevalence of genetic causes of CKD and foundational principles in the role of genetics for CKD management. This webinar also offers an overview of genetic testing logistics. The webinar took place on November 12, 2024.
Module 2 (CME)
Hiding in Plain Sight: The Utility of Genetic Testing in Common Forms of CKD is the second webinar in KDIGO’s four-part webinar series on genetic testing for CKD. In this webinar, Professors Andrew Mallett, MD (Australia), Emilie Cornec-Le Gall, MD (France), Judy Savige, MD (Australia), and Katalin Susztac, MD (United States) discuss the utility of genetic testing in common forms of CKD. The webinar also examines the role of genetic testing when diagnosing cystic kidney disease, glomerular disease, and APOL1 kidney disease. The webinar took place on December 4, 2024.
CME Info:
Module 3 (CME) – January 28, 2025 – Register now!
Module 3 of this series, Understanding Genetic Testing Results: Case-Based Illustrations, will highlight the value of genetic testing in common CKD forms, focusing on clinical presentations of cystic, glomerular, and APOL1-related kidney diseases. Experts discuss classic versus atypical presentations, the spectrum of genetic variants across these conditions, and how genetic diagnoses influence prognostic and family planning decisions. Specific attention is given to APOL1’s relevance for African ancestry populations, implications for treatment, and misclassification risks in hypertensive nephrosclerosis or diabetic nephropathy patients. Download the Module 3 CME info to learn how to earn 1.0 CME credit.
Module 4 (CME) – February 26, 2025 – Register now!
Renal Genetics in 2025 and Beyond: What’s Ahead for this Emerging and Dynamic Field is the last module in the KDIGO Webinar Series on Implementing Genetic Testing for CKD in the Real World Setting.
Join professors Andrew Mallett, MD (Australia), Nine V.A.M. Knoers, MD (The Netherlands), Matthew Sampson, MD (United States), and Ulla Schultheiss, MD (Germany) as they delve into the evolving landscape of genetic testing in nephrology. From advancements in testing methodologies to polygenic risk scores and precision therapies for genetic kidney diseases, this webinar will offer a comprehensive exploration of the rapidly evolving field.
Participants will earn 1.0 CME credit and gain insights into optimizing test evaluation, understanding clinical applications, and addressing the limitations of genetic testing.
Module 4 will offer a forward-looking, conversational session on the evolving field of renal genetics. With an eye to the future, speakers discuss emerging therapies, gaps in variant classification, underrepresentation of diverse ancestry groups, and the rapid pace of discoveries, such as new gene-disease associations and innovative treatments. This module also highlights the potential of polygenic risk scores, pharmacogenomics, and gene-targeted therapies to further transform CKD care in the coming years.
This activity is jointly provided by Global Education Group and KDIGO. This webinar series was supported by an educational grant from Natera.
